This study examines the NCCN Clinical Practice Guidelines for Breast Cancer, a comprehensive framework for managing noninvasive and invasive breast cancer. Focusing on ductal carcinoma and early-stage invasive cancer, the guidelines provide evidence-based recommendations for diagnosis, treatment, and surveillance. As of 2022, these guidelines remain a crucial resource for clinicians, informing best practices in breast cancer management. By synthesizing current research and expert consensus, the NCCN guidelines facilitate standardized care and improved patient outcomes, underscoring their significance in contemporary clinical practice.